HFA Premium Access

Beneficial effects of beta-blockers and ivabradine combination in patients hospitalized due to worsening of heart failure: findings from

Congress Presentation

About the speaker

Professor Yury Lopatin

Volgograd State Medical University, Volgograd (Russian Federation)
16 presentations
0 follower

5 more presentations in this session

Increase of beta-blocker dose and QT interval in heart failure - do we really know it all by heart? Results from CIBIS ELD study.

Speaker: Professor S. Apostolovic (Nis, RS)


Are beta-blockers effective in children with congestive heart failure? - A Cochrane review

Speaker: Doctor S. Alabed (Sheffield, GB)


Quality of life is similar in patients with chronic stable heart failure on vasodilating and non-vasodilating beta blockers.

Speaker: Doctor R. Pharithi (London, GB)


The impact of 12 month beta-blocker therapy on left and right ventricular volumes and ejection fraction and functional status of heart failure patients with midrange ejection fraction

Speaker: Professor M. Poltavskaya (Moscow, RU)


Bisoprolol compared with carvedilol and metoprolol succinate in the treatment of patients with chronic heart failure

Speaker: Doctor H. Froehlich (Heidelberg, DE)


Access the full session

Poster Session 2 - Beta blockers

Speakers: Professor Y. Lopatin, Professor S. Apostolovic, Doctor S. Alabed, Doctor R. Pharithi, Professor M. Poltavskaya...

About the event


Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb